Piller Power Systems, the global sustainable power technology infrastructure supplier, is rapidly expanding its client base in India’s booming Pharmaceutical manufacturing sector.
As an established trusted partner and supplier of power protection equipment to the pharmaceutical sector, Piller clients include top ten companies in the India pharma industry.
Both domestic and international firms with manufacturing capacity in India rely on Piller power conditioning, UPS protection with battery backed and kinetic energy storage solutions which are configured for specific applications in pharma manufacturing.
Shailendra S Bais, Piller India Director, says: “India is known as the world’s pharmacy and forecasts for manufacturing growth prove it. India’s domestic pharmaceutical market value is expected to reach US$42 billion in 2021, likely to reach US$65 billion by 2024 and forecast to expand to US$120-130 billion by 2030. Piller focuses on establishing long term partnerships because it understands that building a facility and providing vital utility infrastructure for pharmaceutical manufacturing represents a company’s single biggest cost and is heavily regulated from the outset.”
The number of deployments of Piller’s latest UB-V electronically coupled UPS at Pharmaceutical manufacturing sites in India is growing. The UB-V Series, built on the renowned reliability of UNIBLOCK ™, is a highly flexible electrically coupled UPS system. The UB-V provides from 1MW to 3.24 MW of UPS protection in one single-module. UB-V UPS operates equally well at low and medium voltage.
The growth of international Indian players such as Zydus Cadila, Cadila Healthcare and Sun Pharmaceuticals, Alembic Schott Glass sets alongside big investments in new manufacturing capacity by the global pharmaceutical giants such as Pfizer, GSK, Sanofi, Abbott Laboratories, Merck and Roche.
“Drug manufacturing in India is undergoing rapid expansion. Domestic and international firms with manufacturing capacity in India use Piller rotary power generation, back up, battery backed and kinetic energy storage solutions,” said Bais.
Inside India’s booming pharmaceutical base the stakes could not be higher. Already the world’s largest producer of generic drugs and maker of half the world’s vaccines, India has 3,000 drug companies and 10,500 manufacturing units.
India is already the largest provider of generic drugs globally and forecasts point to major expansion in manufacturing base capacity. The Indian pharmaceutical sector supplies over 50% of global demand for various vaccines, 40% of generic demand in the US and 25% of all medicine in the UK. Globally, India ranks 3rd in terms of pharmaceutical production by volume and 14th by value.
India’s new pharmaceutical production capacity can rely on clean, stable and conditioned power provided by Piller’s scalable, flexible power infrastructure.
Piller is selected by some of the world’s major manufacturers
Our advanced UB-V Series electrically coupled UPS is ideal for industrial manufacturing applications
About Piller
Piller was founded in Hamburg, Germany in 1909 by engineer Anton Piller. Employing around 1000 people worldwide, Piller is headquartered in Osterode, near Hanover, Germany, with subsidiaries across Europe, America, Asia and Australia. Piller occupies a unique position, being the only company to produce both types of electrically coupled UPS technologies and with kinetic energy storage or battery options. The company also manufactures aircraft ground power units, 50/60Hz frequency converters, static transfer switches and specialist marine generators. With more than 7000 kinetic energy storage devices and over 6000 high power UPS units installed, Piller has more than 300 service personnel taking care of clients across 24 countries. The Piller group is a wholly owned subsidiary of the multi-disciplined global UK engineering and industrial group, Langley Holdings Plc. In 2016, Piller acquired Active Power Inc., the flywheel energy storage specialist.